PTX3 and endothelial dysfunction: Demographic and clinical features and the non-invasive markers of endothelial dysfunction (FMD and PTX3) and atherosclerosis (cIMT and FGF23) were compared between FMF-related AA amyloidosis patients in Group 1 and Group 2.